Results 201 to 210 of about 86,826 (247)

Ferritinophagy Rewires Carnitine‐Dependent Lipid Metabolism to Inhibit PRRSV and IAV Replication

Advanced Science, Volume 13, Issue 45, 13 August 2026.
NCOA4‐mediated ferritinophagy reprograms carnitine metabolism by disrupting Fe‐S cluster biogenesis, thereby establishing an iron‐lipid axis that suppresses various viruses, including PRRSV and IAV. However, viruses counteract this mechanism by degrading NCOA4.
Kaifeng Guan, Chenyang Yuan, Zekun Meng, Yanan Wang, Xueying Zhai, Chunjie Huang, Xiang Zhou, Gaiping Zhang   +7 more
wiley   +1 more source

Small cell lung cancer case report: acute tumor lysis syndrome after chemotherapy and management strategies for high-risk patients. [PDF]

Int J Emerg Med
Han Y, Yue P, Yuan Z.
europepmc   +1 more source

miR155, triplicated in Down syndrome, regulates the development of neural stem cells and GABAergic interneurons in Alzheimer's disease mouse and human iPSC models

Alzheimer's &Dementia, Volume 22, Issue 8, August 2026.
Abstract INTRODUCTION Dysfunctional microRNAs and GABAergic interneurons are features of Alzheimer's disease (AD). The role of neuronal microRNA155 (miR155), elevated in both AD and Down syndrome (DS), remains unknown. METHODS We utilized in silico analyses of published databases, MIR155‐deleted and ‐overexpressing human induced pluripotent stem cell ...
Xiaodong Zhu, Jean‐Vianney Haure‐Mirande, Mesude Bicak, Pengfei Dong, Ilya Kruglikov, Aiqun Li, Aisha Al‐subaie, Valentina Fossati, Scott Noggle, Sam Gandy, Michelle E. Ehrlich   +10 more
wiley   +1 more source

Spontaneous tumor lysis syndrome in an adult with alveolar rhabdomyosarcoma: a challenging diagnosis. [PDF]

Oxf Med Case Reports
Abufara AA, Alsahouri MI, Alsalah QA, Arafat H, Hammouri AG, Aqeel BA.   +5 more
europepmc   +1 more source

Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Pancreatic Adenocarcinoma. [PDF]

ACG Case Rep J
Gusdorf J, Markovitz NH, Ricketts C, Ono Y, Lam BD, Berry J, Dockterman J, Reddy S.   +7 more
europepmc   +1 more source

Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax. [PDF]

Blood Adv
Valtis YK, Nemirovsky D, Derkach A, Sharan S, Kabel C, Ortiz R, Thompson MC, Roeker LE, Geyer MB.   +8 more
europepmc   +1 more source

Successful treatment of tumor lysis syndrome associated with hepatic artery infusion chemotherapy in a patient with hepatocellular carcinoma: a case report. [PDF]

J Med Case Rep
Li M, Zhou YT, Yang BW.
europepmc   +1 more source

Spontaneous Tumor Lysis Syndrome in a Case of Hepatocellular Carcinoma with Sarcomatoid Differentiation. [PDF]

Indian J Surg Oncol
Chhabra R, Vidushi A, Rajpurohit S, Singh J, Osama MA.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tumor Lysis Syndrome

Advances in Chronic Kidney Disease, 2021
Tumor lysis syndrome (TLS) is an oncologic emergency due to massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation. Clinical presentation is characterized by hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia. Acute kidney injury due to tumor lysis is potentiated
Tarek Barbar
exaly   +3 more sources

Tumor Lysis Syndrome

Seminars in Thrombosis and Hemostasis, 2007
Tumor lysis syndrome (TLS) is an important metabolic disorder frequently encountered in the management of a variety of cancers including lymphoma, leukemia, and neuroblastoma. Delayed recognition can result in a variety of biochemical abnormalities resulting in life-threatening complications such as renal failure, arrhythmias, and seizures ...
Ramon V, Tiu, Stavros E, Mountantonakis, Andrew J, Dunbar, Martin J, Schreiber   +3 more
exaly   +5 more sources